Michel Bouvier is an internationally renowned molecular pharmacologist who published extensively (more than 150 papers) on cell signaling through the largest class of therapeutic targets, the G protein-coupled receptors. His pioneering work on inverse agonism and on the role of receptor oligomerization directly impacts on the drug discovery process. He received numerous awards and currently holds the Canada research Chair in Signal Transduction and Molecular Pharmacology. He has been the president of Canadian Hypertension Society (1997-1998), the Chair of the Department of Biochemistry at the Université de Montréal (1997-2005) and is currently the Director of the Groupe de Recherche Universitaire sur le Medicamento at U de Montréal. He also serves on many scientific advisory boards.